[ad_1] Paxlovid, a Pfizer’s coronavirus disease (COVID-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on November 16, 2021. Pfizer/Handout via REUTERS /File Photo SINGAPORE, Feb 3 (Reuters) – Singapore has approved Pfizer’s (PFE.N) oral COVID-19 medicine Paxlovid, its Health Sciences Authority (HSA) said on Thursday. Paxlovid is […]
Continue Reading
[ad_1] Figure: COVID-19, therapeutics, best practices Figure Figure Figure Do the COVID-19 vaccines prevent disease and decrease hospital visits? We know that the Moderna vaccine was found to be 95 percent efficacious after phase 3 trials but had 90 percent efficacy after six months. (Yale Medicine. Dec. 10, 2021; https://bit.ly/3F34zC2.) Another study exploring the effectiveness […]
Continue Reading
[ad_1] File photo UW Medicine highlighted the effects of omicron on their healthcare system in their Jan. 21 town hall. The forum marks two years since the first case of COVID-19 was reported in the United States on Jan. 21, 2020. Omicron holds steady in King County, strains UW Medicine “I would say that the […]
Continue Reading